Granulomatous dermatitis secondary to vemurafenib in a child with Langerhans cell histiocytosis-Reference-Cited by-同舟云学术

Granulomatous dermatitis secondary to vemurafenib in a child with Langerhans cell histiocytosis

Published:2018-09-14 Issue:6 Volume:35 Page:e402-e403
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatr Dermatol

Author:

Chen Lily¹^ORCID,Hsi Andy C.²³,Kothari Alok⁴,Dehner Louis P.³,Hayashi Robert J.⁴,Coughlin Carrie C.⁵^ORCID

Affiliation:

1. School of Medicine; Washington University; St. Louis Missouri

2. Department of Pathology; California Skin Institute; San Jose California

3. Lauren V. Ackerman Laboratory of Surgical Pathology and Dermatopathology Center; St. Louis Children's Hospital; Washington University Medical Center; St. Louis Missouri

4. Division of Hematology/Oncology; Department of Pediatrics; School of Medicine; Washington University; St. Louis Missouri

5. Division of Dermatology; Departments of Medicine and Pediatrics; School of Medicine; Washington University; St. Louis Missouri

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pde.13613/fullpdf

Reference5 articles.

1. Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy;Aricò;Br J Haematol,2016

2. Recurrent BRAF mutations in Langerhans cell histiocytosis;Badalian-Very;Blood,2010

3. Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma;Park;JAMA Dermatol,2014

4. Cutaneous eruptions in patients receiving immune checkpoint blockade: clinicopathologic analysis of the nonlichenoid histologic pattern;Kaunitz;Am J Surg Pathol,2017

5. Chronic granulomatous reaction in patients receiving vaccine immunotherapy for metastatic melanoma;Aria;JAAD Case Rep,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors;Cutis;2023-09

2. Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment;Current Opinion in Pulmonary Medicine;2023-07-06

3. BRAF inhibition and the spectrum of granulomatous reactions;Journal of the American Academy of Dermatology;2021-10

4. Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review;Pediatric Blood & Cancer;2021-09-26

5. Cutaneous adverse events in children treated with vemurafenib for refractory BRAF V600E mutated Langerhans cell histiocytosis;Pediatric Blood & Cancer;2021-06-09